argus

Jagsonpal Pharmaceuticals Limited

NSE: JAGSNPHARMINE048B010351,577 Cr

Timeline

Time (IST)TypeMEventSrc
27 Aug, 07:51 pmJagsonpal Pharmaceuticals Ltd - 507789 - Reg. 34 (1) Annual Report.bse
27 Aug, 05:41 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'providing a web-link of the Annual Report 2025-26 to members'.nse
27 Aug, 05:39 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement Under Regulation 30-SEBI (LODR) Regulations, 2015bse
24 Aug, 11:56 amJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 27950 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 '.nse
04 Aug, 04:23 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Transcriptnse
04 Aug, 04:20 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Transcriptnse
04 Aug, 04:19 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
30 Jul, 05:30 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jul, 05:30 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Link of Recordingnse
29 Jul, 06:48 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about change in Managementnse
29 Jul, 06:45 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Managementbse
29 Jul, 06:36 pmJagsonpal Pharmaceuticals Ltd - 507789 - Corporate Action- Record Date: September 04, 2026bse
29 Jul, 06:34 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about 'Grant of 1,20,000 ESOP under JPL ESOP Plan 2022nse
29 Jul, 06:24 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 29, 2026, titled "Press Release for Unaudited Financial Results for quarter ended June 30, 2026 ".nse
29 Jul, 06:23 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
29 Jul, 06:20 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
29 Jul, 06:10 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Presentationnse
29 Jul, 05:34 pmJagsonpal Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 04-Sep-2026.nse
29 Jul, 05:19 pmJagsonpal Pharmaceuticals Ltd - 507789 - Unaudited Results For The Quarter Ended June 30, 2026bse
29 Jul, 05:09 pmJagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
29 Jul, 05:01 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Outcome for Outcome Of Board Meeting Held On July 29, 2026 Along With Unaudited (Standalone) Financial Results For The Quarter June 30, 2026bse
22 Jul, 04:18 pmJagsonpal Pharmaceuticals Ltd - 507789 - Board Meeting Intimation for Prior Intimation Of Board Meetingbse
17 Jul, 04:54 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Updates on Acquisition of Aequitas Healthcare Private Limited'.nse
17 Jul, 04:52 pmJagsonpal Pharmaceuticals Ltd - 507789 - General-Updatesbse
15 Jul, 04:33 pm'Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of 94,000 Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 )'.nse
08 Jul, 04:50 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Updates on Acquisition of Aequitas Healthcare Private Limited.'.nse
08 Jul, 04:49 pmJagsonpal Pharmaceuticals Ltd - 507789 - General-Updatesbse
07 Jul, 01:40 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Updates on Acquisition of Aequitas Healthcare Private Limited'.nse
07 Jul, 01:39 pmJagsonpal Pharmaceuticals Ltd - 507789 - General Updatesbse
30 Jun, 03:21 pmJagsonpal Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
29 Jun, 04:49 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 29, 2026, titled "Press Release on Acquisition of Aequitas Healthcare Private Limited. ".nse
29 Jun, 04:46 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
29 Jun, 04:34 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Acquisition of Aequitas Healthcare Private Limited.nse
29 Jun, 04:30 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Acquisitionbse
25 Jun, 06:25 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 25, 2026, titled "Press Release on appointment of Independent director of the Company".nse
25 Jun, 06:23 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
25 Jun, 06:21 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about change in Managementnse
25 Jun, 06:20 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Change in Director(s) of the company.nse
25 Jun, 06:18 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Anil Kumar Matai (DIN: 03122685) as Non- Executive Independent Director of the company w.e.f. Jun 25, 2026.nse
25 Jun, 06:16 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Managementbse
25 Jun, 06:13 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Directoratebse
04 Jun, 04:44 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022 ( JPL ESOP 2022 )'.nse
03 Jun, 12:32 pmInfinity Holdings has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
02 Jun, 03:49 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Closure of Buy Back with effect from Jun 02, 2026nse
02 Jun, 03:48 pmJagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Closure of Buy Backbse
28 May, 03:10 pmJagsonpal Pharmaceuticals Ltd - 507789 - Compliances-Reg.24(A)-Annual Secretarial Compliancebse
25 May, 01:21 pmJagsonpal Pharmaceuticals Ltd - 507789 - Post Buyback Public Announcementbse
18 May, 06:07 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
18 May, 06:03 pmJagsonpal Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
18 May, 05:58 pmJagsonpal Pharmaceuticals Limited has informed the Exchange regarding Resignation of Resignation of an Independent Director. as Non- Executive Independent Director of the company w.e.f. May 18, 2026.nse